The Securities Commission has decided to revoke a cease trade order (CTO) that was previously issued against ZoomMed Inc. The CTO was initially put in place because the company failed to file certain continuous disclosure materials as required by Ontario securities law. ZoomMed Inc. has since addressed these defaults by updating its continuous disclosure filings. Consequently, the Commission, under the authority of Section 144 of the Securities Act (R.S.O. 1990, c. S.5, as amended) and guided by National Policy 11-207, has determined that the conditions for revoking the CTO have been met. The decision, which applies to both Québec and Ontario, confirms that the company is now in compliance with the necessary disclosure requirements, and therefore, the CTO has been officially revoked.
